Ken Griffin Azenta, Inc. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$45.84 - $62.29 $866,376 - $1.18 Million	18,900 Added 48.21%	58,100 $2.81 Million
Q2 2024 Aug 14, 2024	BUY	$50.27 - $59.04 $211,134 - $247,968	4,200 Added 12.0%	39,200 $2.06 Million
Q1 2024 May 15, 2024	SELL	$57.82 - $67.51 $190,806 - $222,783	-3,300 Reduced 8.62%	35,000 $2.11 Million
Q4 2023 Feb 14, 2024	SELL	$44.02 - $66.3 $1.08 Million - $1.62 Million	-24,500 Reduced 39.01%	38,300 $2.49 Million
Q3 2023 Nov 14, 2023	SELL	$44.08 - $57.76 $4.34 Million - $5.69 Million	-98,500 Reduced 61.07%	62,800 $3.15 Million
Q2 2023 Aug 14, 2023	BUY	$36.45 - $46.68 $969,570 - $1.24 Million	26,600 Added 19.75%	161,300 $7.53 Million
Q1 2023 May 15, 2023	BUY	$39.51 - $61.95 $2.84 Million - $4.46 Million	72,000 Added 114.83%	134,700 $6.01 Million
Q4 2022 Feb 14, 2023	BUY	$38.6 - $62.07 $945,700 - $1.52 Million	24,500 Added 64.14%	62,700 $3.65 Million
Q3 2022 Nov 14, 2022	SELL	$42.86 - $77.02 $561,466 - $1.01 Million	-13,100 Reduced 25.54%	38,200 $1.64 Million

336

49.4M

186K

405K

Ticker AZTA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 75,020,400
Market Cap $3.52B
Description
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sampl...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.